Sindy Kim
Impact in
-
- Advanced Breast Cancer Therapies
- Cancer-related cognitive impairment studies
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Advanced Breast Cancer Therapies 21
- Oncology 10
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Dennis J. Slamon (11 shared papers)Eustratios Bananis (9 shared papers)Richard S. Finn (12 shared papers)Hope S. Rugo (7 shared papers)Nadia Harbeck (5 shared papers)Seock‐Ah Im (7 shared papers)Xin Huang (13 shared papers)Dongrui R. Lu (8 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)The Breast (2 papers)Future Oncology (2 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesIrelandGermany
In The Last Decade
Sindy Kim
20 papers receiving 689 citations
Sindy Kim's Hit Papers
Peers
Comparison fields: 5 of 38
- Pulmonary and Respiratory Medicine 581
- Cancer Research 174
- Oncology 309
- Genetics 72
- Genetics 34
Countries citing papers authored by Sindy Kim
This map shows the geographic impact of Sindy Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sindy Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sindy Kim more than expected).
Fields of papers citing papers by Sindy Kim
This network shows the impact of papers produced by Sindy Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sindy Kim. The network helps show where Sindy Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside Sindy Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study Hit paper breakdown → | 2022 | 129 |
| 2 | 2020 | 119 | |
| 3 | Overall survival (OS) with first-line palbociclib plus letrozole (PAL+LET) versus placebo plus letrozole (PBO+LET) in women with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer (ER+/HER2− ABC): Analyses from PALOMA-2. Hit paper breakdown → | 2022 | 112 |
| 4 | Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer Hit paper breakdown → | 2024 | 93 |
| 5 | 2018 | 59 | |
| 6 | 2017 | 53 | |
| 7 | 2021 | 37 | |
| 8 | 2021 | 30 | |
| 9 | 2021 | 21 | |
| 10 | 2019 | 10 | |
| 11 | 2021 | 7 | |
| 12 | 2015 | 6 | |
| 13 | 2023 | 4 | |
| 14 | 2015 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2015 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2023 | 2 | |
| 19 | 2015 | 1 | |
| 20 | 2015 | 1 |
About Sindy Kim
Sindy Kim is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Public Health, Environmental and Occupational Health and Genetics, having authored 21 papers that have together received 696 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (21 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (4 papers), Cancer-related Molecular Pathways (3 papers), Breast Cancer Treatment Studies (3 papers), Male Breast Health Studies (2 papers), Chronic Lymphocytic Leukemia Research (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (581 citations), Cancer Research (174 citations), Oncology (309 citations), Genetics (72 citations) and Genetics (34 citations). Sindy Kim has collaborated with scholars based in United States, Ireland and Germany. Frequent co-authors include Dennis J. Slamon, Eustratios Bananis, Richard S. Finn, Hope S. Rugo, Nadia Harbeck, Seock‐Ah Im, Xin Huang, Dongrui R. Lu, Igor Bondarenko and Karen A. Gelmon. Their work appears in journals such as Journal of Clinical Oncology, The Breast, Future Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.